FDA Talks Drug Safety With China, But Visas For Staff Still Elusive
Agency unable to place more inspectors in China even as Howard Sklamberg visits Beijing.
You may also be interested in...
After receiving delayed visas, additional FDA is inspectors and other staff can relocate to China office; Gottlieb also announces increase in international mail facility staff.
New deputy commissioner Howard Sklamberg tells “The Pink Sheet” that globalization of the drug supply eventually will become more commonplace, and ideally less of a concern, for American consumers.
The agency is waiting for approval to locate 10 new drug inspectors in China.